These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: 3H-Dopamine binding sites differ in rat striatum and pituitary.
    Author: Sokoloff P, Martres MP, Delandre M, Redouane K, Schwartz JC.
    Journal: Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):221-7. PubMed ID: 6493362.
    Abstract:
    3H-Domperidone (3H-DOMP) binding sites were compared in rat striatum and pituitary, regarding the effects of the non-hydrolysable GTP analog, Gpp(NH)p and inhibition by various dopamine (DA) antagonists. Gpp(NH)p (0.1 mM) elicited in both tissues a rightward shift in DA concentration-inhibition curves, but the changes in either IC50 values or pseudo-Hill coefficients were larger in pituitary than in striatum. Computer analysis of the data showed that, in the presence of Gpp(NH)p, the curve obtained in striatum is best explained by the presence of two classes of binding site, a high-affinity site (Ki = 95 nM, 27% of total binding) and a low-affinity site (Ki = 5, 100 nM, 73% of total binding), whereas in pituitary only a low-affinity site (Ki = 5,070 nM) could be detected. In striatum, several discriminant benzamide derivatives (DBD), (-)-sulpiride and recently developed compounds, allowed to distinguish two components among 3H-DOMP binding sites: a high-affinity site representing one-third of total binding and a low-affinity component displaying a 8-17 fold lower affinity. Classical neuroleptics like haloperidol, chlorpromazine and metoclopramide inhibited striatal 3H-DOMP binding in a monophasic manner. In pituitary a single component could be detected for all tested antagonists including the DBD and Ki values for the latters were identical to those found for the low-affinity component in striatum.(ABSTRACT TRUNCATED AT 250 WORDS)
    [Abstract] [Full Text] [Related] [New Search]